EP Patent

EP4682151A2 — Prodrugs of alpha-ketoglutarate, alpha-ketobutyrate, alpha-ketoisovalerate, and alpha-ketoisohexanoate, and uses thereof

Assigned to University of California · Expires 2026-01-21 · 0y expired

What this patent protects

The present disclosure provides compounds and compositions capable of extending lifespan, for use in the treatment of age-related disease or disorders.

USPTO Abstract

The present disclosure provides compounds and compositions capable of extending lifespan, for use in the treatment of age-related disease or disorders.

Drugs covered by this patent

Patent Metadata

Patent number: EP4682151A2
Jurisdiction: EP
Classification: —
Expires: 2026-01-21
Drug substance claim: No
Drug product claim: No
Assignee: University of California
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.